You can buy or sell BSX and other stocks, options, and ETFs commission-free!
Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA. The listed name for BSX is Boston Scientific Corp.
Michael F. Mahoney
52 Week High
52 Week Low
Boston Scientific to acquire Preventice Solutions for $925 million in cash, up to $300 million in potential milestone payments
Boston Scientific Inc. BSX, +1.08% said Thursday it has agreed to acquire privately held Preventice Solutions Inc. for an upfront payment of $925 million and up
— per share
Available Feb 3, Pre-Market